Intensity Therapeutics, Inc.
INTS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001567264
No open-market purchases or sales by Intensity Therapeutics, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $4.79M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Intensity Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −19 vs. Q4 2025
- Shares held
- 180.3K
- −3.08M (−94.5%) vs. Q4 2025
- Total value
- $1.06M
- −$255.8K (−19.4%) vs. Q4 2025
- New holders
- 6
- 0 more added
- Sold out
- 25
- 8 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INTS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $4.79M |
| Q1 2026 | 14 | $1.06M |
| Q4 2025 | 35 | $1.58M |
| Q3 2025 | 26 | $721.2K |
| Q2 2025 | 27 | $606.6K |
| Q1 2025 | 21 | $5.10M |
| Q4 2024 | 20 | $4.79M |
| Q3 2024 | 20 | $6.65M |
| Q2 2024 | 23 | $8.23M |
| Q1 2024 | 18 | $8.49M |
| Q4 2023 | 17 | $4.39M |
| Q3 2023 | 10 | $1.19M |
| Q2 2023 | 2 | $170.2K |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Intensity Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kingsbury Capital Investment Advisors LLC | 38,054 | $223.8K | 0.21% | +38,054 | New |
| Geode Capital Management, LLC | 26,019 | $153.0K | 0.00% | −434,229−94.3% | Reduced |
| Sapient Capital LLC | 26,006 | $152.9K | 0.00% | −624,145−96.0% | Reduced |
| Nano Cap New Millennium Growth Fund L P | 25,000 | $147.0K | 0.14% | +25,000 | New |
| Sentinus, LLC | 23,294 | $137.0K | 0.01% | −472,616−95.3% | Reduced |
| Vanguard Capital Management LLC | 16,841 | $99.0K | 0.00% | +16,841 | New |
| Mesirow Financial Investment Management, Inc. | 14,118 | $83.0K | 0.00% | −236,882−94.4% | Reduced |
| Vanguard Fiduciary Trust Co | 9,121 | $53.6K | 0.00% | +9,121 | New |
| GWM Advisors LLC | 1,148 | $6.75K | 0.00% | −23,852−95.4% | Reduced |
| Wells Fargo & Company | 200 | $1.18K | 0.00% | +200 | New |
| Advisor Group Holdings, Inc. | 200 | $1.18K | 0.00% | +200 | New |
| UBS Group AG | 192 | $1.13K | 0.00% | −25,205−99.2% | Reduced |
| Tower Research Capital LLC (TRC) | 67 | $394 | 0.00% | −21,465−99.7% | Reduced |
| Morgan Stanley | 20 | $118 | 0.00% | −480−96.0% | Reduced |
| Legacy Advisors, LLC | 0 | $0 | 0.00% | −153,447−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −143,136−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −136,200−100.0% | Sold out |
| Brown Advisory Inc | 0 | $0 | 0.00% | −130,000−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Stonebridge Financial Group, LLC | 0 | $0 | 0.00% | −77,377−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −75,543−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −69,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −62,755−100.0% | Sold out |
| Sigma Planning Corp | 0 | $0 | 0.00% | −56,432−100.0% | Sold out |
| IHT Wealth Management, LLC | 0 | $0 | 0.00% | −50,483−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −48,722−100.0% | Sold out |
| Ewa, LLC | 0 | $0 | 0.00% | −41,354−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −34,829−100.0% | Sold out |
| One Charles Private Wealth Services, LLC | 0 | $0 | 0.00% | −31,800−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −30,191−100.0% | Sold out |
| QTR Family Wealth, LLC | 0 | $0 | 0.00% | −17,420−100.0% | Sold out |
| Sassicaia Capital Advisers LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Marex Group plc | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| T3 Companies, LLC | 0 | $0 | 0.00% | −13,600−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Beacon Pointe Advisors, LLC | 0 | $0 | 0.00% | −10,199−100.0% | Sold out |
| Pensionmark Financial Group, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −584−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −88−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |